Virus News and Research

Latest Virus News and Research

WHO official rejects claims agency overhyped threat of H1N1

Keiji Fukuda, the special adviser to the WHO director general on pandemic influenza, on Thursday dismissed allegations that the agency exaggerated the threat of the H1N1 (swine flu) pandemic and has been influenced by the pharmaceutical industry, the Washington Post reports.

18 Jan 2010

Studies show treatment success for chronic hepatitis C may be predicted by rapid virological response

The likelihood of treatment success of 48 wk peg-interferon (PEG-IFN) plus ribavirin (RBV) therapy for chronic hepatitis C may be predicted by viral kinetics on therapy. In particular, recent studies have shown that sustained virological response (SVR) can be predicted by a rapid virological response (RVR), and an early virological response (EVR).

17 Jan 2010

Early immune response needed for 'hit-and-hide' cancer viruses

Retroviruses such as HIV and HTLV-1 don't hit-and-run, they hit-and-hide. They slip into host cells and insert their own DNA into the cell's DNA, and from this refuge they establish an infection that lasts a lifetime.

14 Jan 2010

Whitley urges public to get vaccinated against H1N1 influenza virus

With several months left in the influenza season and growing supplies of vaccine, now is an opportune time to get vaccinated against the 2009 H1N1 influenza virus, says Richard Whitley, M.D., director of the University of Alabama at Birmingham (UAB) Division of Pediatric Infectious Diseases and current president of the Infectious Diseases Society of America (IDSA).

13 Jan 2010

Teenage girls are not receiving HPV vaccine, says report

In 2006, the Food and Drug Administration (FDA) approved the Human Papilloma Virus (HPV) vaccine for girls and women ages 9 to 26. As part of Cervical Cancer Awareness Month in January, experts at The University of Texas M. D. Anderson Cancer Center review what we have learned about this controversial vaccine in the past four years.

13 Jan 2010

New genetic evidence can improve avian influenza surveillance programs

Genetic analyses of avian influenza in wild birds can help pinpoint likely carrier species and geographic hot spots where Eurasian viruses would be most likely to enter North America, according to new U.S. Geological Survey research.

13 Jan 2010

Emory University researchers invent a new weapon to monitor mosquito-borne diseases

Emory University researchers believe they have come up with the cheapest, most efficient way yet to monitor adult mosquitoes and the deadly diseases they carry, from malaria to West Nile Virus. Emory has filed a provisional patent on the Prokopack mosquito aspirator, but the inventors have provided simple instructions for how to make it in the Journal of Medical Entomology.

13 Jan 2010

Record-breaking 8,300 health care professionals participate in online H1N1 vaccination education program

A record-breaking 8,300 front-line health care professionals participated in an accredited, online education program about H1N1 vaccination in November 2009 alone.

13 Jan 2010

NIH, D.C. Department of Health partner to decrease the rate of new HIV infections

Officials from the National Institutes of Health and the city of Washington, D.C. today announced the new D.C. Partnership for HIV/AIDS Progress, a collaborative research initiative between NIH and the D.C. Department of Health designed to decrease the rate of new HIV infections in the city, improve the health of district residents living with HIV infection, and strengthen the city's response to the HIV/AIDS epidemic.

13 Jan 2010

moksha8 receives approval to import and use peramivir in patients with H1N1 influenza A in Mexico

moksha8 and BioCryst today announced that moksha8 has been granted approval from COFEPRIS (The Federal Commission for the Protection against Sanitary Risk) in Mexico for the importation and use of peramivir in patients with influenza associated with the 2009 H1N1 influenza A strain.

13 Jan 2010

ETMC Athens gears up for next flu pandemic

Throughout the month of September, East Texas Medical Center, Athens (ETMC Athens) saw a 42% average surge in number of patients per day due to publicity of the H1N1 virus and took it in stride. Improved efficiencies in the Emergency Department facilitated by a process improvement firm, Compirion Healthcare, allowed the hospital to absorb the volume and still see an improvement in quality.

13 Jan 2010

Donald Danforth Plant Science Center researchers enter into research collaboration with Dow AgroSciences

Researchers working at the Donald Danforth Plant Science Center have entered into a research collaboration with Dow AgroSciences LLC, a wholly owned subsidiary of The Dow Chemical Company, to study how its EXZACTTM Precision Technology can help improve the root crop cassava for millions of people living in developing countries.

13 Jan 2010

HaloSource signs agreement with WAL for the use of HaloPure disinfection cartridges in WAL’s products

HaloSource, a leading clean water company, has signed an agreement with WAL (S.A.), the Swiss-based international water filtration products company, for the use of HaloSource’s revolutionary HaloPure® disinfection cartridges in WAL’s jug and pitcher products.

13 Jan 2010

NOVAVAX completes pre-clinical safety and efficacy study of its RSV vaccine candidate

Novavax, Inc. announced today that it has successfully completed a pre-clinical safety and efficacy study of its RSV vaccine candidate in cotton rats. Results from this study are needed to support an Investigational New Drug (IND) application to advance this novel recombinant F protein particle based RSV (RSV-F) vaccine candidate into clinical development. This vaccine candidate is composed of recombinant 'F' or 'fusion' protein of RSV which is used by the virus to infect and fuse with cells in the respiratory tract and cause disease.

13 Jan 2010

Media outlets examine U.S. plans for leftover H1N1 vaccine, efforts to keep flu vaccine production on track

After working to ensure the U.S. had access to enough H1N1 (swine flu) vaccine, health officials may now face a new dilemma - a vaccine surplus, the Associated Press reports.

12 Jan 2010

VaxInnate grants license to Biological E. to develop and commercialize recombinant H1N1 vaccine in India

VaxInnate Corporation today announced that it has granted Indian biopharmaceutical company Biological E. Limited a license to its recombinant H1N1 pandemic swine flu vaccine and is collaborating to facilitate the manufacture, clinical development and commercialization of the vaccine in India.

12 Jan 2010

Phase I clinical trial of XRX-001 for yellow fever initiated

Xcellerex, Inc. today announced that it has initiated a Phase I clinical trial of XRX-001, a novel, prophylactic vaccine against yellow fever, a tropical virus disease that is often fatal.

12 Jan 2010

Life Technologies to acquire AcroMetrix

Life Technologies Corporation, a provider of innovative life science solutions, today announced that it has signed a definitive agreement to acquire AcroMetrix, for an undisclosed amount.

12 Jan 2010

NanoViricides outlines its technology and current drug programs at Biotech Showcase conference

NanoViricides, Inc. (the "Company"), reports that the Company has been invited to present on January 12th at the Biotech Showcase™, a conference designed to showcase promising companies and technologies for partnering and investment purposes.

12 Jan 2010

HGS reports commercialization of late-stage products for systemic lupus and chronic hepatitis C

Human Genome Sciences, Inc. today will announce its priority goals for 2010 and report on the Company’s increasing momentum toward commercialization of late-stage products for systemic lupus and chronic hepatitis C in a presentation by H. Thomas Watkins, President and Chief Executive Officer, to financial analysts and investors at the 28th Annual JPMorgan Healthcare Conference in San Francisco.

12 Jan 2010

Virus News and Research

Latest Virus News and Research

WHO official rejects claims agency overhyped threat of H1N1

Studies show treatment success for chronic hepatitis C may be predicted by rapid virological response

Early immune response needed for 'hit-and-hide' cancer viruses

Whitley urges public to get vaccinated against H1N1 influenza virus

Teenage girls are not receiving HPV vaccine, says report

New genetic evidence can improve avian influenza surveillance programs

Emory University researchers invent a new weapon to monitor mosquito-borne diseases

Record-breaking 8,300 health care professionals participate in online H1N1 vaccination education program

NIH, D.C. Department of Health partner to decrease the rate of new HIV infections

moksha8 receives approval to import and use peramivir in patients with H1N1 influenza A in Mexico

ETMC Athens gears up for next flu pandemic

Donald Danforth Plant Science Center researchers enter into research collaboration with Dow AgroSciences

HaloSource signs agreement with WAL for the use of HaloPure disinfection cartridges in WAL’s products

NOVAVAX completes pre-clinical safety and efficacy study of its RSV vaccine candidate

Media outlets examine U.S. plans for leftover H1N1 vaccine, efforts to keep flu vaccine production on track

VaxInnate grants license to Biological E. to develop and commercialize recombinant H1N1 vaccine in India

Phase I clinical trial of XRX-001 for yellow fever initiated

Life Technologies to acquire AcroMetrix

NanoViricides outlines its technology and current drug programs at Biotech Showcase conference

HGS reports commercialization of late-stage products for systemic lupus and chronic hepatitis C

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Virus News and Research

Latest Virus News and Research

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Newsletters you may be interested in